Prognostic nomograms for predicting long‐term overall survival in spindle cell melanoma: a population‐based study

Background There are few research findings on the survival prognosis of spindle cell melanoma (SCM), which is an unusual kind of melanoma. The purpose of this study was to develop a thorough nomogram for predicting the overall survival (OS) of patients with SCM and to assess its validity by comparing it with the conventional American Joint Committee on Cancer (AJCC) staging system. Methods The Surveillance, Epidemiology, and End Results database was searched, and 2,015 patients with SCM were selected for the analysis. The patients were randomly divided into training (n = 1,410) and validation (n = 605) cohorts by using R software. Multivariate Cox regression was performed to identify predictive factors. A nomogram was established based on these characteristics to predict OS in SCM. The calibration curve, concordance index (C-index), area under the receiver operating characteristic curve, and decision-curve analysis were utilized to assess the accuracy and reliability of the model. The net reclassification improvement and integrated discrimination improvement were also applied in this model to evaluate its differences with the AJCC model. Results The developed nomogram suggests that race, AJCC stage, chemotherapy status, regional node examination status, marital status, and sex have the greatest effects on OS in SCM. The nomogram had a higher C-index than the AJCC staging system (0.751 versus 0.633 in the training cohort and 0.747 versus 0.650 in the validation cohort). Calibration plots illustrated that the model was capable of being calibrated. These criteria demonstrated that the nomogram outperforms the AJCC staging system alone. Conclusion The nomogram developed in this study is sufficiently reliable for forecasting the risk and prognosis of SCM, which may facilitate personalized treatment recommendations in upcoming clinical trials.

[1]  Guiyu Wang,et al.  Association Between Radiotherapy and Death From Cardiovascular Disease Among Patients With Cancer: A Large Population‐Based Cohort Study , 2022, Journal of the American Heart Association.

[2]  Tao Huang,et al.  Data mining in clinical big data: the frequently used databases, steps, and methodological models , 2021, Military Medical Research.

[3]  Xianling Cong,et al.  A Nomogram Combining a Four-Gene Biomarker and Clinical Factors for Predicting Survival of Melanoma , 2021, Frontiers in Oncology.

[4]  T. Sullivan,et al.  An eyebrow lump: malignant spindle cell melanoma , 2021, The Medical journal of Australia.

[5]  Huiyan Sun,et al.  Nomogram based on autophagy related genes for predicting the survival in melanoma , 2021, BMC Cancer.

[6]  Fabiana C. P. S. Lopes,et al.  UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review. , 2020, JAMA dermatology.

[7]  Xuewen Xu,et al.  A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma , 2020, Annals of Surgical Oncology.

[8]  J. Company-Quiroga,et al.  Spindle-cell malignant melanoma , 2020, Indian journal of dermatology, venereology and leprology.

[9]  Jeffrey F Scott,et al.  Racial differences in time to treatment for melanoma , 2020, Journal of the American Academy of Dermatology.

[10]  Jun Lyu,et al.  Brief introduction of medical database and data mining technology in big data era , 2020, Journal of evidence-based medicine.

[11]  D. van Klaveren,et al.  Development and validation of a nomogram to predict recurrence and melanoma‐specific mortality in patients with negative sentinel lymph nodes , 2018, The British journal of surgery.

[12]  Lei Feng,et al.  Spindle cell melanoma: Incidence and survival, 1973-2017 , 2018, Oncology letters.

[13]  J. Ro,et al.  Cutaneous Spindle Cell Neoplasms: Pattern-Based Diagnostic Approach. , 2018, Archives of pathology & laboratory medicine.

[14]  Lei Feng,et al.  Desmoplastic melanoma versus spindle cell melanoma , 2018, Medicine.

[15]  Jeffrey E Gershenwald,et al.  Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[16]  S. Mousa,et al.  Current status and future direction in the management of malignant melanoma , 2017, Melanoma research.

[17]  A. Gesierich,et al.  Completion Dissection or Observation for Sentinel‐Node Metastasis in Melanoma , 2017, The New England journal of medicine.

[18]  S. Ra,et al.  A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas. , 2015, Archives of pathology & laboratory medicine.

[19]  Benjamin R Saville,et al.  Decision curve analysis. , 2015, JAMA.

[20]  Ming-Hui Chen,et al.  Marital status and survival in patients with cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Lu Tian,et al.  A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data , 2013, Statistics in medicine.

[22]  Y. Shang,et al.  Estrogen and cancer. , 2013, Annual review of physiology.

[23]  A. Lazar,et al.  BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma , 2012, Journal of cutaneous pathology.

[24]  Donald L Weaver,et al.  Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Ewout W Steyerberg,et al.  Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.

[26]  J. Gómez-Millán Radiation therapy in the elderly: more side effects and complications? , 2009, Critical reviews in oncology/hematology.

[27]  Chetna N. Purohit,et al.  Immunohistochemical Distinction of Cutaneous Spindle Cell Carcinoma , 2008, The American Journal of dermatopathology.

[28]  M. Guo,et al.  Diagnostic challenges of metastatic spindle cell melanoma on fine‐needle aspiration specimens , 2008, Cancer.

[29]  Scott D. Cohen,et al.  Social support and chronic kidney disease: an update. , 2007, Advances in chronic kidney disease.

[30]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[31]  K. Schulz,et al.  Bias and causal associations in observational research , 2002, The Lancet.

[32]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  H. Lynch,et al.  Psychologic Aspects of Cancer Genetic Testing: A Research Update for Clinicians , 1997 .

[34]  T. Longacre,et al.  Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. , 1996, The American journal of surgical pathology.

[35]  C. Zanardo,et al.  Marital status and stage of cancer at diagnosis: A systematic review , 2018, European journal of cancer care.

[36]  L. J. Geisse,et al.  Iris melanomas. , 1985, American journal of ophthalmology.